Photophysical and electrochemical properties of 1,3-bis(2-pyridylimino)isoindolate platinum(II) derivatives.

A series of twelve platinum(II) complexes of the form (N^N^N)PtX have been synthesized and characterized where N^N^N is 1,3-bis(2-pyridylimino)isoindolate ligands (BPI) or BPI ligands whose aryl moieties are substituted with tert-butyl, nitro, alkoxy, iodo or chloro groups, and X is a chloride, fluoride, cyano, acetate, phenyl or 4-(dimethylamino)phenyl ligand. All complexes display at least one irreversible oxidation and two reversible reduction waves at potentials dependent on the position and the electron donating or withdrawing nature of both X and the substituted N^N^N ligand. Broad room temperature phosphorescence ranging in energy from 594 to 680 nm was observed from the complexes, with quantum efficiencies ranging from 0.01 to 0.05. The efficiency of emission is dictated largely by nonradiative processes since the rate constants for nonradiative deactivation [(1.1-100) × 10(5) s(-1)] show greater variation than those for radiative decay [(0.57-4.0) × 0(4) s(-1)]. Nonradiative deactivation for compounds with X = Cl follow the energy gap law, i.e. the nonradiative rate constants increase exponentially with decreasing emission energy. Deactivation of the excited state appears to be strongly influenced by a non-planar distortion of the BPI ligand.

Dendrimers ended by non-symmetrical azadiphosphonate groups: synthesis and immunological properties.

The synthesis and characterization of new series of phosphorus-containing dendrimers ended by non-symmetrical azamonophosphonates, or azadiphosphonates, or azadiphosphonic acid salts are reported. The sodium salts of the non-symmetrical azadiphosphonic dendrimers are soluble in water. Their influence towards human immune blood cells is assayed ex vivo.

Tailored control and optimisation of the number of phosphonic acid termini on phosphorus-containing dendrimers for the ex-vivo activation of human monocytes.

The syntheses of a series of phosphonic acid-capped dendrimers is described. This collection is based on a unique set of dendritic structural parameters-cyclo(triphosphazene) core, benzylhydrazone branches and phosphonic acid surface-and was designed to study the influence of phosphonate (phosphonic acid) surface loading towards the activation of human monocytes ex vivo. Starting from the versatile hexachloro-cyclo(triphosphazene) N(3)P(3)Cl(6), six first-generation dendrimers were obtained, bearing one to six full branches, that lead to 4, 8, 12, 16, 20 and 24 phosphonate termini, respectively. The surface loading was also explored at the limit of dense packing by means of a first-generation dendrimer having a cyclo(tetraphosphazene) core and bearing 32 termini, and with a first-generation dendrimer based on a AB(2)/CD(5) growing pattern and bearing 60 termini. Human monocyte activation by these dendrimers confirms the requirement of the whole dendritic structure for bioactivity and identifies the dendrimer bearing four branches, thus 16 phosphonate termini, as the most bioactive.

Design of phosphorylated dendritic architectures to promote human monocyte activation.

As first defensive line, monocytes are a pivotal cell population of innate immunity. Monocyte activation can be relevant to a range of immune conditions and responses. Here we present new insights into the activation of monocytes by a series of phosphonic acid-terminated, phosphorus-containing dendrimers. Various dendritic or subdendritic structures were synthesized and tested, revealing the basic structural requirements for monocyte activation. We showed that multivalent character and phosphonic acid capping of dendrimers are crucial for monocyte targeting and activation. Confocal videomicroscopy showed that a fluorescein-tagged dendrimer binds to isolated monocytes and gets internalized within a few seconds. We also found that dendrimers follow the phagolysosomial route during internalization by monocytes. Finally, we performed fluorescence resonance energy transfer (FRET) experiments between a specifically designed fluorescent dendrimer and phycoerythrin-coupled antibodies. We showed that the typical innate Toll-like receptor (TLR)-2 is clearly involved, but not alone, in the sensing of dendrimers by monocytes. In conclusion, phosphorus-containing dendrimers appear as precisely tunable nanobiotools able to target and activate human innate immunity and thus prove to be good candidates to develop new drugs for immunotherapies.

Thioacylation reactions for the surface functionalization of phosphorus-containing dendrimers.

The functionalization of phosphorus-containing dendrimers was easily achieved through thioacylation reactions involving new dendrimers capped with dithioester end groups and various functionalized amines. These reactions were successfully applied to the first generation (12 end groups) and the third generation of the dendrimer (48 end groups) and allowed their functionalization by various primary or secondary amines, alcohols, glycols, and azides. [reaction: see text]